Back to Search
JOSEPH GIBBONS, MD
MD
Hematology & Oncology Physician
NPI: 1639198450IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-045535(OH)
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1979
Research & Publications (20)
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235116·J Clin Oncol·2008
3-trial
A qualitative study of amlodipine and its related compounds by electrospray ionization tandem mass spectrometry.
PMID 16676312·Rapid Commun Mass Spectrom·2006
8-other
Case history of serious altitude decompression sickness following rapid rate of ascent.
PMID 12793542·Aviat Space Environ Med·2003
8-other
Technical note: the effect of the 4-mm-collimator output factor on gamma knife dose distributions.
PMID 14604431·J Appl Clin Med Phys·2003
8-other
Linear accelerators used for IMRT should be designed as small field, high intensity, intermediate energy units. Against the proposition.
PMID 12462718·Med Phys·2002
4-observational
Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
PMID 19291285·World J Surg Oncol·2009
5-case
Point/counterpoint. To ensure that target volumes are not underirradiated when respiratory motion may affect the dose distribution, 4D dose calculations should be performed.
PMID 19235366·Med Phys·2009
8-other
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2.
PMID 19531356·Dev Cell·2009
7-preclinical
ATP-competitive inhibitors of the mammalian target of rapamycin: design and synthesis of highly potent and selective pyrazolopyrimidines.
PMID 19645448·J Med Chem·2009
7-preclinical
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
PMID 19584280·Cancer Res·2009
7-preclinical
Independent calculation of dose from a helical TomoTherapy unit.
PMID 19223830·J Appl Clin Med Phys·2009
8-other
The microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties.
PMID 19132373·Cancer Chemother Pharmacol·2009
8-other
Sleep-related breathing in children with mucopolysaccharidosis.
PMID 19562504·J Inherit Metab Dis·2009
8-other
Why people rehearse their memories: frequency of use and relations to the intensity of emotions associated with autobiographical memories.
PMID 19657960·Memory·2009
8-other
Comparative and functional characterization of intragenic tandem repeats in 10 Aspergillus genomes.
PMID 19056904·Mol Biol Evol·2009
8-other
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
PMID 18414865·Cancer Chemother Pharmacol·2009
3-trial
Efficacy of a commercially available post-thaw bovine semen sexing kit in both single-ovulating and hyperstimulated cows.
PMID 19282115·Anim Reprod Sci·2009
2-rct
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses.
PMID 19032723·Br J Clin Pharmacol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-8500
Quick Facts
- NPI
- 1639198450
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile